N-(Piperazinyl)-4-oxo-1H-quinoline-2-carboxamide hydrochloride

ID: ALA1933856

PubChem CID: 14457843

Max Phase: Preclinical

Molecular Formula: C14H16ClN3O2

Molecular Weight: 257.29

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cl.O=C(c1cc(=O)c2ccccc2[nH]1)N1CCNCC1

Standard InChI:  InChI=1S/C14H15N3O2.ClH/c18-13-9-12(14(19)17-7-5-15-6-8-17)16-11-4-2-1-3-10(11)13;/h1-4,9,15H,5-8H2,(H,16,18);1H

Standard InChI Key:  LQEDNJGVCLLDJJ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 20 21  0  0  0  0  0  0  0  0999 V2000
    5.8558   -3.5864    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.5665   -3.9976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2764   -3.5873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2784   -2.7635    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.5642   -2.3515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8480   -2.7635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5642   -2.7683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5630   -3.5941    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2766   -4.0063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2748   -2.3562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9889   -2.7646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9924   -3.5962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7102   -4.0068    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4294   -3.5903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4260   -2.7587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7034   -2.3435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6989   -1.5201    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1436   -4.0002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1459   -4.8236    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.9731   -0.6498    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
 14 18  1  0
  7  8  2  0
 18 19  2  0
 18  1  1  0
  8  9  1  0
  9 12  2  0
 11 10  2  0
 11 16  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 10  7  1  0
 16 17  2  0
 11 12  1  0
M  END

Associated Targets(non-human)

Hippocampus (432 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 257.29Molecular Weight (Monoisotopic): 257.1164AlogP: 0.57#Rotatable Bonds: 1
Polar Surface Area: 65.20Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 12.28CX Basic pKa: 7.72CX LogP: 0.68CX LogD: 0.19
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.78Np Likeness Score: -0.80

References

1. Nagy K, Plangár I, Tuka B, Gellért L, Varga D, Demeter I, Farkas T, Kis Z, Marosi M, Zádori D, Klivényi P, Fülöp F, Szatmári I, Vécsei L, Toldi J..  (2011)  Synthesis and biological effects of some kynurenic acid analogs.,  19  (24): [PMID:22079867] [10.1016/j.bmc.2011.10.029]

Source